How to stop disproportionation of a hydrochloride salt of a very weakly basic compound in a non-clinical suspension formulation-Reference-Cited by-同舟云学术

How to stop disproportionation of a hydrochloride salt of a very weakly basic compound in a non-clinical suspension formulation

Published:2021-09 Issue: Volume:606 Page:120875
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Ojala Krista,Salmia Jukka,Shevchenko Anna,Ylikotila Johanna,Korjamo Timo,van Veen Bert,Koistinen Piritta,Malmström Chira,Laakso Sirpa,Bansal Indu,Samiulla D.S.,Juppo Anne

Funder

Horizon Pharma

OMRON Corporation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference49 articles.

1. Effect of salt form on chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms;Badawy;Int. J. Pharm.,2001

2. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity;Balakrishnan;J. Pharm. Sci.,2004

3. Predicting drug absorption and the effects of food on oral bioavailability;Benet;Bull. Tech. Gattefosse,2006

4. Solubility of doxycycline in aqueous solution;Bogardus;J. Pharm. Sci.,1979

5. 420PPhase I/II study of ODM-203, a selective dual FGFR/VEGFR inhibitor, in patients with advanced solid tumours;Bono;Ann. Oncol.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping Advantages and Challenges in Analytical Development for Fixed Dose Combination Products, a Review;Journal of Pharmaceutical Sciences;2024-08

2. Drug and formulation development processes;From Current to Future Trends in Pharmaceutical Technology;2024

3. Exploiting common ion addition to accelerate zolpidem hemitartrate release from Eudragit EPO extrudates;International Journal of Pharmaceutics;2023-07

4. Exploring the solid form landscape of the antifungal drug isavuconazole: crystal structure analysis, phase transformation behavior and dissolution performance;CrystEngComm;2021